Covid-19 Impact on Global Cancer Supportive Care Drugs Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cancer Supportive Care Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Cancer Supportive Care Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 G-CSFs (Granulocyte-colony Stimulating Factors)
1.4.3 ESAs (Erythropoiesis Stimulating Agents)
1.4.4 Anti-emetics
1.4.5 Bisphosphonates
1.4.6 Opioids
1.4.7 NSAIDs
1.5 Market by Application
1.5.1 Global Cancer Supportive Care Drugs Market Share by Application: 2020 VS 2026
1.5.2 Chemotherapy Therapy
1.5.3 Radiation Therapy
1.6 Coronavirus Disease 2019 (Covid-19): Cancer Supportive Care Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the Cancer Supportive Care Drugs Industry
1.6.1.1 Cancer Supportive Care Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Cancer Supportive Care Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Cancer Supportive Care Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Cancer Supportive Care Drugs Market Perspective (2015-2026)
2.2 Cancer Supportive Care Drugs Growth Trends by Regions
2.2.1 Cancer Supportive Care Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cancer Supportive Care Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Cancer Supportive Care Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Cancer Supportive Care Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Cancer Supportive Care Drugs Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Cancer Supportive Care Drugs Players by Market Size
3.1.1 Global Top Cancer Supportive Care Drugs Players by Revenue (2015-2020)
3.1.2 Global Cancer Supportive Care Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Cancer Supportive Care Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cancer Supportive Care Drugs Market Concentration Ratio
3.2.1 Global Cancer Supportive Care Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cancer Supportive Care Drugs Revenue in 2019
3.3 Cancer Supportive Care Drugs Key Players Head office and Area Served
3.4 Key Players Cancer Supportive Care Drugs Product Solution and Service
3.5 Date of Enter into Cancer Supportive Care Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Cancer Supportive Care Drugs Historic Market Size by Type (2015-2020)
4.2 Global Cancer Supportive Care Drugs Forecasted Market Size by Type (2021-2026)
5 Cancer Supportive Care Drugs Breakdown Data by Application (2015-2026)
5.1 Global Cancer Supportive Care Drugs Market Size by Application (2015-2020)
5.2 Global Cancer Supportive Care Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Cancer Supportive Care Drugs Market Size (2015-2020)
6.2 Cancer Supportive Care Drugs Key Players in North America (2019-2020)
6.3 North America Cancer Supportive Care Drugs Market Size by Type (2015-2020)
6.4 North America Cancer Supportive Care Drugs Market Size by Application (2015-2020)
7 Europe
7.1 Europe Cancer Supportive Care Drugs Market Size (2015-2020)
7.2 Cancer Supportive Care Drugs Key Players in Europe (2019-2020)
7.3 Europe Cancer Supportive Care Drugs Market Size by Type (2015-2020)
7.4 Europe Cancer Supportive Care Drugs Market Size by Application (2015-2020)
8 China
8.1 China Cancer Supportive Care Drugs Market Size (2015-2020)
8.2 Cancer Supportive Care Drugs Key Players in China (2019-2020)
8.3 China Cancer Supportive Care Drugs Market Size by Type (2015-2020)
8.4 China Cancer Supportive Care Drugs Market Size by Application (2015-2020)
9 Japan
9.1 Japan Cancer Supportive Care Drugs Market Size (2015-2020)
9.2 Cancer Supportive Care Drugs Key Players in Japan (2019-2020)
9.3 Japan Cancer Supportive Care Drugs Market Size by Type (2015-2020)
9.4 Japan Cancer Supportive Care Drugs Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Cancer Supportive Care Drugs Market Size (2015-2020)
10.2 Cancer Supportive Care Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cancer Supportive Care Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Cancer Supportive Care Drugs Market Size by Application (2015-2020)
11 India
11.1 India Cancer Supportive Care Drugs Market Size (2015-2020)
11.2 Cancer Supportive Care Drugs Key Players in India (2019-2020)
11.3 India Cancer Supportive Care Drugs Market Size by Type (2015-2020)
11.4 India Cancer Supportive Care Drugs Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Cancer Supportive Care Drugs Market Size (2015-2020)
12.2 Cancer Supportive Care Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Cancer Supportive Care Drugs Market Size by Type (2015-2020)
12.4 Central & South America Cancer Supportive Care Drugs Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Amgen
13.1.1 Amgen Company Details
13.1.2 Amgen Business Overview and Its Total Revenue
13.1.3 Amgen Cancer Supportive Care Drugs Introduction
13.1.4 Amgen Revenue in Cancer Supportive Care Drugs Business (2015-2020))
13.1.5 Amgen Recent Development
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Details
13.2.2 Johnson & Johnson Business Overview and Its Total Revenue
13.2.3 Johnson & Johnson Cancer Supportive Care Drugs Introduction
13.2.4 Johnson & Johnson Revenue in Cancer Supportive Care Drugs Business (2015-2020)
13.2.5 Johnson & Johnson Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview and Its Total Revenue
13.3.3 Merck Cancer Supportive Care Drugs Introduction
13.3.4 Merck Revenue in Cancer Supportive Care Drugs Business (2015-2020)
13.3.5 Merck Recent Development
13.4 Roche
13.4.1 Roche Company Details
13.4.2 Roche Business Overview and Its Total Revenue
13.4.3 Roche Cancer Supportive Care Drugs Introduction
13.4.4 Roche Revenue in Cancer Supportive Care Drugs Business (2015-2020)
13.4.5 Roche Recent Development
13.5 Helsinn Healthcare
13.5.1 Helsinn Healthcare Company Details
13.5.2 Helsinn Healthcare Business Overview and Its Total Revenue
13.5.3 Helsinn Healthcare Cancer Supportive Care Drugs Introduction
13.5.4 Helsinn Healthcare Revenue in Cancer Supportive Care Drugs Business (2015-2020)
13.5.5 Helsinn Healthcare Recent Development
13.6 Heron Pharma
13.6.1 Heron Pharma Company Details
13.6.2 Heron Pharma Business Overview and Its Total Revenue
13.6.3 Heron Pharma Cancer Supportive Care Drugs Introduction
13.6.4 Heron Pharma Revenue in Cancer Supportive Care Drugs Business (2015-2020)
13.6.5 Heron Pharma Recent Development
13.7 Tesaro
13.7.1 Tesaro Company Details
13.7.2 Tesaro Business Overview and Its Total Revenue
13.7.3 Tesaro Cancer Supportive Care Drugs Introduction
13.7.4 Tesaro Revenue in Cancer Supportive Care Drugs Business (2015-2020)
13.7.5 Tesaro Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of TablesTable 1. Cancer Supportive Care Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Cancer Supportive Care Drugs Revenue
Table 3. Ranking of Global Top Cancer Supportive Care Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cancer Supportive Care Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of G-CSFs (Granulocyte-colony Stimulating Factors)
Table 6. Key Players of ESAs (Erythropoiesis Stimulating Agents)
Table 7. Key Players of Anti-emetics
Table 8. Key Players of Bisphosphonates
Table 9. Key Players of Opioids
Table 10. Key Players of NSAIDs
Table 11. COVID-19 Impact Global Market: (Four Cancer Supportive Care Drugs Market Size Forecast Scenarios)
Table 12. Opportunities and Trends for Cancer Supportive Care Drugs Players in the COVID-19 Landscape
Table 13. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 14. Key Regions/Countries Measures against Covid-19 Impact
Table 15. Proposal for Cancer Supportive Care Drugs Players to Combat Covid-19 Impact
Table 16. Global Cancer Supportive Care Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 17. Global Cancer Supportive Care Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 18. Global Cancer Supportive Care Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 19. Global Cancer Supportive Care Drugs Market Share by Regions (2015-2020)
Table 20. Global Cancer Supportive Care Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 21. Global Cancer Supportive Care Drugs Market Share by Regions (2021-2026)
Table 22. Market Top Trends
Table 23. Key Drivers: Impact Analysis
Table 24. Key Challenges
Table 25. Cancer Supportive Care Drugs Market Growth Strategy
Table 26. Main Points Interviewed from Key Cancer Supportive Care Drugs Players
Table 27. Global Cancer Supportive Care Drugs Revenue by Players (2015-2020) (Million US$)
Table 28. Global Cancer Supportive Care Drugs Market Share by Players (2015-2020)
Table 29. Global Top Cancer Supportive Care Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Supportive Care Drugs as of 2019)
Table 30. Global Cancer Supportive Care Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 31. Key Players Headquarters and Area Served
Table 32. Key Players Cancer Supportive Care Drugs Product Solution and Service
Table 33. Date of Enter into Cancer Supportive Care Drugs Market
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Cancer Supportive Care Drugs Market Size by Type (2015-2020) (Million US$)
Table 36. Global Cancer Supportive Care Drugs Market Size Share by Type (2015-2020)
Table 37. Global Cancer Supportive Care Drugs Revenue Market Share by Type (2021-2026)
Table 38. Global Cancer Supportive Care Drugs Market Size Share by Application (2015-2020)
Table 39. Global Cancer Supportive Care Drugs Market Size by Application (2015-2020) (Million US$)
Table 40. Global Cancer Supportive Care Drugs Market Size Share by Application (2021-2026)
Table 41. North America Key Players Cancer Supportive Care Drugs Revenue (2019-2020) (Million US$)
Table 42. North America Key Players Cancer Supportive Care Drugs Market Share (2019-2020)
Table 43. North America Cancer Supportive Care Drugs Market Size by Type (2015-2020) (Million US$)
Table 44. North America Cancer Supportive Care Drugs Market Share by Type (2015-2020)
Table 45. North America Cancer Supportive Care Drugs Market Size by Application (2015-2020) (Million US$)
Table 46. North America Cancer Supportive Care Drugs Market Share by Application (2015-2020)
Table 47. Europe Key Players Cancer Supportive Care Drugs Revenue (2019-2020) (Million US$)
Table 48. Europe Key Players Cancer Supportive Care Drugs Market Share (2019-2020)
Table 49. Europe Cancer Supportive Care Drugs Market Size by Type (2015-2020) (Million US$)
Table 50. Europe Cancer Supportive Care Drugs Market Share by Type (2015-2020)
Table 51. Europe Cancer Supportive Care Drugs Market Size by Application (2015-2020) (Million US$)
Table 52. Europe Cancer Supportive Care Drugs Market Share by Application (2015-2020)
Table 53. China Key Players Cancer Supportive Care Drugs Revenue (2019-2020) (Million US$)
Table 54. China Key Players Cancer Supportive Care Drugs Market Share (2019-2020)
Table 55. China Cancer Supportive Care Drugs Market Size by Type (2015-2020) (Million US$)
Table 56. China Cancer Supportive Care Drugs Market Share by Type (2015-2020)
Table 57. China Cancer Supportive Care Drugs Market Size by Application (2015-2020) (Million US$)
Table 58. China Cancer Supportive Care Drugs Market Share by Application (2015-2020)
Table 59. Japan Key Players Cancer Supportive Care Drugs Revenue (2019-2020) (Million US$)
Table 60. Japan Key Players Cancer Supportive Care Drugs Market Share (2019-2020)
Table 61. Japan Cancer Supportive Care Drugs Market Size by Type (2015-2020) (Million US$)
Table 62. Japan Cancer Supportive Care Drugs Market Share by Type (2015-2020)
Table 63. Japan Cancer Supportive Care Drugs Market Size by Application (2015-2020) (Million US$)
Table 64. Japan Cancer Supportive Care Drugs Market Share by Application (2015-2020)
Table 65. Southeast Asia Key Players Cancer Supportive Care Drugs Revenue (2019-2020) (Million US$)
Table 66. Southeast Asia Key Players Cancer Supportive Care Drugs Market Share (2019-2020)
Table 67. Southeast Asia Cancer Supportive Care Drugs Market Size by Type (2015-2020) (Million US$)
Table 68. Southeast Asia Cancer Supportive Care Drugs Market Share by Type (2015-2020)
Table 69. Southeast Asia Cancer Supportive Care Drugs Market Size by Application (2015-2020) (Million US$)
Table 70. Southeast Asia Cancer Supportive Care Drugs Market Share by Application (2015-2020)
Table 71. India Key Players Cancer Supportive Care Drugs Revenue (2019-2020) (Million US$)
Table 72. India Key Players Cancer Supportive Care Drugs Market Share (2019-2020)
Table 73. India Cancer Supportive Care Drugs Market Size by Type (2015-2020) (Million US$)
Table 74. India Cancer Supportive Care Drugs Market Share by Type (2015-2020)
Table 75. India Cancer Supportive Care Drugs Market Size by Application (2015-2020) (Million US$)
Table 76. India Cancer Supportive Care Drugs Market Share by Application (2015-2020)
Table 77. Central & South America Key Players Cancer Supportive Care Drugs Revenue (2019-2020) (Million US$)
Table 78. Central & South America Key Players Cancer Supportive Care Drugs Market Share (2019-2020)
Table 79. Central & South America Cancer Supportive Care Drugs Market Size by Type (2015-2020) (Million US$)
Table 80. Central & South America Cancer Supportive Care Drugs Market Share by Type (2015-2020)
Table 81. Central & South America Cancer Supportive Care Drugs Market Size by Application (2015-2020) (Million US$)
Table 82. Central & South America Cancer Supportive Care Drugs Market Share by Application (2015-2020)
Table 83. Amgen Company Details
Table 84. Amgen Business Overview
Table 85. Amgen Product
Table 86. Amgen Revenue in Cancer Supportive Care Drugs Business (2015-2020) (Million US$)
Table 87. Amgen Recent Development
Table 88. Johnson & Johnson Company Details
Table 89. Johnson & Johnson Business Overview
Table 90. Johnson & Johnson Product
Table 91. Johnson & Johnson Revenue in Cancer Supportive Care Drugs Business (2015-2020) (Million US$)
Table 92. Johnson & Johnson Recent Development
Table 93. Merck Company Details
Table 94. Merck Business Overview
Table 95. Merck Product
Table 96. Merck Revenue in Cancer Supportive Care Drugs Business (2015-2020) (Million US$)
Table 97. Merck Recent Development
Table 98. Roche Company Details
Table 99. Roche Business Overview
Table 100. Roche Product
Table 101. Roche Revenue in Cancer Supportive Care Drugs Business (2015-2020) (Million US$)
Table 102. Roche Recent Development
Table 103. Helsinn Healthcare Company Details
Table 104. Helsinn Healthcare Business Overview
Table 105. Helsinn Healthcare Product
Table 106. Helsinn Healthcare Revenue in Cancer Supportive Care Drugs Business (2015-2020) (Million US$)
Table 107. Helsinn Healthcare Recent Development
Table 108. Heron Pharma Company Details
Table 109. Heron Pharma Business Overview
Table 110. Heron Pharma Product
Table 111. Heron Pharma Revenue in Cancer Supportive Care Drugs Business (2015-2020) (Million US$)
Table 112. Heron Pharma Recent Development
Table 113. Tesaro Company Details
Table 114. Tesaro Business Overview
Table 115. Tesaro Product
Table 116. Tesaro Revenue in Cancer Supportive Care Drugs Business (2015-2020) (Million US$)
Table 117. Tesaro Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Cancer Supportive Care Drugs Market Share by Type: 2020 VS 2026
Figure 2. G-CSFs (Granulocyte-colony Stimulating Factors) Features
Figure 3. ESAs (Erythropoiesis Stimulating Agents) Features
Figure 4. Anti-emetics Features
Figure 5. Bisphosphonates Features
Figure 6. Opioids Features
Figure 7. NSAIDs Features
Figure 8. Global Cancer Supportive Care Drugs Market Share by Application: 2020 VS 2026
Figure 9. Chemotherapy Therapy Case Studies
Figure 10. Radiation Therapy Case Studies
Figure 11. Cancer Supportive Care Drugs Report Years Considered
Figure 12. Global Cancer Supportive Care Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Cancer Supportive Care Drugs Market Share by Regions: 2020 VS 2026
Figure 14. Global Cancer Supportive Care Drugs Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Cancer Supportive Care Drugs Market Share by Players in 2019
Figure 17. Global Top Cancer Supportive Care Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Supportive Care Drugs as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Cancer Supportive Care Drugs Revenue in 2019
Figure 19. North America Cancer Supportive Care Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Cancer Supportive Care Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Cancer Supportive Care Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Cancer Supportive Care Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Cancer Supportive Care Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Cancer Supportive Care Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Cancer Supportive Care Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Amgen Revenue Growth Rate in Cancer Supportive Care Drugs Business (2015-2020)
Figure 28. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Johnson & Johnson Revenue Growth Rate in Cancer Supportive Care Drugs Business (2015-2020)
Figure 30. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Merck Revenue Growth Rate in Cancer Supportive Care Drugs Business (2015-2020)
Figure 32. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Roche Revenue Growth Rate in Cancer Supportive Care Drugs Business (2015-2020)
Figure 34. Helsinn Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Helsinn Healthcare Revenue Growth Rate in Cancer Supportive Care Drugs Business (2015-2020)
Figure 36. Heron Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Heron Pharma Revenue Growth Rate in Cancer Supportive Care Drugs Business (2015-2020)
Figure 38. Tesaro Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Tesaro Revenue Growth Rate in Cancer Supportive Care Drugs Business (2015-2020)
Figure 40. Bottom-up and Top-down Approaches for This Report
Figure 41. Data Triangulation
Figure 42. Key Executives Interviewed